The complexities and some of the potential pitfalls of the presidential transition period are described in a newly updated report from the Congressional Research Service.
“A variety of events, decisions, and activities contribute to what some may characterize as the unfolding drama of a presidential transition. Interparty transitions in particular might be contentious.”
The report addresses the use of executive orders, record preservation and clemency actions by the outgoing Administration, as well as cybersecurity, budget preparation, political appointments, and so forth. See Presidential Transitions: Issues Involving Outgoing and Incoming Administrations, updated November 16, 2016.
Other new and updated reports from the Congressional Research Service include the following.
Counting Electoral Votes: An Overview of Procedures at the Joint Session, Including Objections by Members of Congress, updated November 15, 2016
The Congressional Review Act: Frequently Asked Questions, updated November 17, 2016
Infrastructure Finance and Debt to Support Surface Transportation Investment, updated November 17, 2016
Prevalence of Mental Illness in the United States: Data Sources and Estimates, updated November 16, 2016
The Patient Protection and Affordable Care Act’s (ACA’s) Transitional Reinsurance Program, November 16, 2016
CRISPR: A Revolutionary Tool for Editing the Code of Life?, CRS Insight, November 17, 2016
Certain U.S. Laws for Foreign Workers Draw Fire from India in the WTO, CRS Legal Sidebar, November 16, 2016
Justice Department’s Role in Cyber Incident Response, CRS Insight, November 15, 2016
Naval Station Guantanamo Bay: History and Legal Issues Regarding Its Lease Agreements, updated November 17, 2016
Iran Sanctions, updated November 16, 2016
Yemen: Civil War and Regional Intervention, updated November 16, 2016
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.